Catalyst Wire Dossier Catalyst Wire Dossier

1790GAHB vaccine

1790GAHB · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 1790GAHB vaccine, covering 2019-03-07 to 2019-03-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study [Phase 1]

See pricing